In this issue:
Simultaneous vs. delayed resection of liver metastasis in colorectal cancer
1986-2016 obesity prevalence trends in obesity-related cancers
Neoadjuvant mFOLFIRINOX vs. mFOLFIRINOX + hypofractionated radiotherapy for borderline resectable pancreatic adenocarcinoma
3 vs. 6 months of adjuvant oxaliplatin & fluoropyrimidine-based therapy in stage III colon cancer
Tislelizumab vs. chemo as second-line treatment in advanced or metastatic ESCC
HPD during PD-1 blockade in advanced gastric cancer
Outcomes in advanced gastric or gastroesophageal cancer treated in RCTs vs. real-world clinical settings
Feasibility of nab-paclitaxel & capecitabine after failure of gemcitabine & platinum in advanced biliary tract cancer
Please login below to download this issue (PDF)